Uncover key drivers, emerging technologies, and competitive movements shaping the radiation dose optimisation software market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Brain Disease Device And Software Market by the end of 2030?

The brain disease device and software market size has experienced rapid expansion in recent years. This market is anticipated to increase from $15.59 billion in 2025 to $17.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. Historically, this growth can be attributed to the limited availability of brain disease diagnostic tools, the growing prevalence of neurological disorders, rising hospital and clinic infrastructure, early-stage adoption of telemedicine solutions, and a dependence on traditional brain imaging techniques.

The brain disease device and software market is projected for significant expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $25.21 billion, demonstrating a compound annual growth rate (CAGR) of 10.0%. Key drivers for this growth throughout the forecast period include innovations in wearable and AI-powered brain disease devices, increased funding for neurorehabilitation technologies, the broadening of home care and remote patient monitoring options, a growing need for brain data management software, and expanded research in neuroinformatics and cognitive evaluation technologies. Significant trends expected during this time frame involve the increased use of neurostimulation and brain monitoring tools, the incorporation of telemedicine and remote patient monitoring, an uptick in cognitive assessment and neurofeedback software development, a heightened emphasis on individualized treatments for brain disorders, and the widespread application of neuroimaging and data analytics solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27230&type=smp

What Drivers Are Shaping Future Opportunities In The Brain Disease Device And Software Market?

The expanding occurrence of neurological conditions is projected to boost the brain disease device and software market in the future. Neurological disorders are health issues impacting the brain, spinal cord, and nerves, leading to diverse symptoms like cognitive, motor, and sensory difficulties. The rising incidence of these disorders is associated with the world’s aging population, as aging progressively impairs nerve function, decreases brain adaptability, and heightens oxidative stress, facilitating the onset and progression of these conditions. Brain disease devices and software aid in managing neurological disorders through facilitating early detection and ongoing tracking. They enable prompt actions via sophisticated AI and data analytics, thereby enhancing patient well-being and treatment efficacy. For example, in July 2024, as reported by the National Health Service, a UK-based government agency, 487,432 patients had been diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, marking an increase of 3,155 cases from May 31, 2024. Consequently, the growing prevalence of neurological disorders is stimulating the expansion of the brain disease device and software market.

Which Segment Groups Are Influencing The Brain Disease Device And Software Market?

The brain disease device and software market covered in this report is segmented –

1) By Type: Brain Disease Device, Brain Disease Software

2) By Technology: Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies

3) By Application: Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Other Applications

4) By End-User: Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories

Subsegments:

1) By Brain Disease Device: Neurostimulation Devices, Brain Imaging Devices, Brain Monitoring Devices, Brain-Computer Interface Devices, Neurorehabilitation Devices

2) By Brain Disease Software: Brain Imaging Analysis Software, Cognitive Assessment Software, Neurofeedback Software, Brain Data Management Software, Neurological Disorder Diagnostic Software

How Are New Market Trends Shaping The Landscape Of The Brain Disease Device And Software Market?

Leading companies in the brain disease device and software market are prioritizing the adoption of innovative technologies, such as artificial intelligence (AI)-driven brain imaging analytics, to enhance the early and accurate detection, monitoring, and management of neurodegenerative conditions like Alzheimer’s disease and dementia. Artificial intelligence-driven brain imaging analytics incorporates advanced software platforms that apply machine-learning models to MRI and other neuroimaging data. This allows for the identification of subtle microstructural alterations in brain tissue that conventional volumetric imaging might overlook, thereby enabling an earlier and more sensitive diagnosis. For instance, in January 2025, Oxford Brain Diagnostics Ltd., a UK-based medtech company, secured U.S. Food and Drug Administration (FDA) 510(k) clearance and then launched CDM Insights, a cloud-native software solution built on its proprietary Cortical Disarray Measurement (CDM) technology. This tool processes routine 1.5 T and 3 T MRI scans to produce novel measures of cortical thickness and microstructural disarray in grey matter, offering objective, quantifiable indicators of neurodegeneration. Following these regulatory approvals, the company commenced its commercial rollout across healthcare systems in the US and UK, assisting clinicians with early diagnosis, disease monitoring, and treatment stratification.

Who Are The Major Companies Operating In The Brain Disease Device And Software Market?

Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/brain-disease-device-and-software-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Brain Disease Device And Software Market?

North America was the largest region in the brain disease device and software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Brain Disease Device And Software Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27230&type=smp

Browse Through More Reports Similar to the Global Brain Disease Device And Software Market 2026, By The Business Research Company

Building Insulation Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report

Technical Insulation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

Building Thermal Insulation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-thermal-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company